ÌÇÐÄÆƽâ°æ

Sales distribution of Chugai Pharmaceutical Co., Ltd. in 2022, by disease area

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

May 2023

Region

Japan

Survey time period

2022

Supplementary notes

**The overseas share includes products against Hemophilia A and Actemra which was approved as a COVID-19 medication in the EU.
**The primary share includes medication against Hemophilia A and neurological pathologies.

Citation formats

Chugai pharmaceutical's sales share 2022, by disease area

Published by A. Minhas, May 31, 2023
In the fiscal year 2022, the Japanese company Chugai Pharmaceutical Co., Ltd stated that approximately ** percent of their total sales derived from products made for overseas markets. Due to the EU's approval of "Actemra" as a COVID-19 treatment, this segment has outperformed Chugai's domestic oncological product range.
Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

10

Other regions

10

Related statistics

10

Further Content: You might find this interesting as well

Topics

Pharmaceutical industry in Denmark Global pharmaceutical industryPharmaceutical industry in the U.S.Novo NordiskPharmaceutical industry in the UK
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.